UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) P-accRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 11.3 | 18.7 | 1.2 | 2.7 | 1.2 | |
+/-Cat | -6.2 | 9.3 | 5.8 | 5.8 | -0.7 | |
+/-B’mrk | - | 0.5 | -4.6 | 5.2 | -3.6 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 16/05/2024 | USD 441.62 | |
Day Change | -0.11% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | LU0085953304 | |
Fund Size (Mil) 16/05/2024 | USD 214.75 | |
Share Class Size (Mil) 16/05/2024 | USD 105.47 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 24/04/2024 | 1.80% |
Investment Objective: UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) P-acc |
The Fund’s investment objective consists in generating strong capital appreciation with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. This sub-fund is a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests at least two thirds of its assets worldwide in shares or other equity interests of companies in developed or emerging markets, which mainly promote United Nations Sustainable Development Goal 3 (Good Health and Well-Being). The focus is on companies that capitalise on healthcare transformation. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Matthew Konosky 31/08/2016 | ||
Scott Wilkin 31/08/2016 | ||
Inception Date 27/05/1998 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) P-acc | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 10.24 |
UnitedHealth Group Inc | Healthcare | 9.01 |
AstraZeneca PLC | Healthcare | 7.14 |
Koninklijke Philips NV | Healthcare | 5.76 |
Novartis AG Registered Shares | Healthcare | 5.05 |
Increase Decrease New since last portfolio | ||
UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) P-acc |